The deal range was $4.50-$4.75. TD Cowen and Wedbush acted as joint book running managers for the offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLUE:
- Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Monte Rosa Therapeutics expects cash and cash equivalents sufficient into 1H26
- Monte Rosa Therapeutics reports Q1 EPS (53c), consensus (57c)
- Monte Rosa Therapeutics Corporate Presentation Release
- Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue